Estimating Vaccines' Value and Impact
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Vaccines and Public Health".
Deadline for manuscript submissions: 15 August 2024 | Viewed by 5050
Special Issue Editor
Special Issue Information
Dear Colleagues,
Estimating the value and public health impact of vaccines is critical to ensure evidence-based policy decision making in nearly all stages, from vaccine development to the introduction/implementation of vaccines in low-resource settings. To foster public health equity, as well as estimate value to local and national economies, concerted efforts are needed to increase the understanding of the full value of vaccination. Such value goes beyond direct disease prevention and can, for example, include impacts on the life course of vaccinated recipients, on the wider community, and on entire health systems.
We are pleased to invite you to contribute with your research work to provide readers (e.g., member states, global policymakers, funding entities, and/or the vaccine R&D community) with insights on how the “full” value of vaccines can be assessed or was assessed by you. This can be carried out through concrete assessments that you undertook or by offering methodological advice that can help the growing community of researchers and implementers to inform as well as optimize responses to vaccine-preventable diseases.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but not limited to) the following:
- Reviews
- Full value of vaccine assessment concept and approaches;
- Current estimation of value in the vaccine space and areas for improvement as well as expansion (e.g., equity, broader perspectives, etc.);
- Standardization of methods to support robust assessments of the impact as well as value of vaccines.
- Original research articles on
- Full value of vaccine assessments;
- Impact assessment of vaccination in low-resource settings;
- Efforts to support policy decision making on vaccine introduction/prioritzation.
Dr. Philipp Lambach
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- full value of vaccine assessment
- impact
- value
- economic
